7826 - 7850 of 8808 Results
Title
Year
-
OPENTitle: Allogeneic bone marrow-derived mesenchymal stem cells in the aging kidney: secondary results of a Parkinson’s disease clinical trialJournal Name: Stem Cell Research & TherapyPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13287-025-04577-yBest OA location URL: https://stemcellres.biomedcentral.com/counter/pdf/10.1186/s13287-025-04577-yCitation Count: 0
-
OPENTitle: Task-Oriented Intelligent Solution to Measure Parkinson’s Disease Tremor SeverityJournal Name: Journal of Healthcare EngineeringPublisher: WileyVol: 2021Issue #:Start Page: 1End Page: 15Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2021/9624386Best OA location URL: https://downloads.hindawi.com/journals/jhe/2021/9624386.pdfCitation Count: 6
-
RESTRICTEDTitle: Who will remain tremor dominant? The possible role of cognitive reserve in the time course of two common Parkinson’s disease motor subtypesJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 125Issue #: 6Start Page: 1007End Page: 1011Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-018-1859-3Citation Count: 10
-
OPENTitle: Multishank Thin‐Film Neural Probes and Implantation System for High‐Resolution Neural Recording ApplicationsJournal Name: Advanced Electronic MaterialsPublisher: WileyVol: 9Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/aelm.202200883Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/aelm.202200883Citation Count: 13
-
OPENTitle: The role of autophagy in synucleinopathy: clearance versus spread of α-synucleinJournal Name: Autophagy ReportsPublisher: Informa UK LimitedVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/27694127.2025.2577406Best OA location URL: https://doi.org/10.1080/27694127.2025.2577406Citation Count: 0
-
OPENTitle: T2-Imaging Changes in the Nigrosome-1 Relate to Clinical Measures of Parkinson’s DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2016.00174Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2016.00174/pdfCitation Count: 10
-
RESTRICTEDTitle: Brain age prediction and early neurodegeneration detection using contrastive learning on brain biomechanics: a retrospective, multicentre studyJournal Name: eBioMedicinePublisher: Elsevier BVVol: 121Issue #:Start Page: 105996End Page: 105996Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105996Best OA location URL: https://www.thelancet.com/pdfs/journals/ebiom/PIIS2352-3964(25)00440-2.pdfCitation Count: 0
-
OPENTitle: Parkinson’s Disease Caregiving, Level of Care Burden, Caregiving-Related Strain, and Caregiver HealthJournal Name: HealthcarePublisher: MDPI AGVol: 13Issue #: 13Start Page: 1520End Page: 1520Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/healthcare13131520Best OA location URL: https://www.mdpi.com/2227-9032/13/13/1520/pdf?version=1750911470Citation Count: 0
-
OPENTitle: A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 2Start Page: 329End Page: 332Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27259Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27259Citation Count: 16
-
RESTRICTEDTitle: Which dyskinesia scale best detects treatment response?Journal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 3Start Page: 341End Page: 346Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25321Citation Count: 82
-
OPENTitle: Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodentsJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 522Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.23612Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cne.23612Citation Count: 4
-
OPENTitle: Minimal Clinically Important Difference for UPDRS‐III in Daily PracticeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 4Start Page: 448End Page: 450Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12632Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12632Citation Count: 46
-
OPENTitle: Neuroprotective Strategies and Cell-Based Biomarkers for Manganese-Induced Toxicity in Human Neuroblastoma (SH-SY5Y) CellsJournal Name: BiomoleculesPublisher: MDPI AGVol: 14Issue #: 6Start Page: 647End Page: 647Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom14060647Best OA location URL: https://www.mdpi.com/2218-273X/14/6/647/pdf?version=1717136963Citation Count: 5
-
RESTRICTEDTitle: Association of liver fibrosis with cognitive decline in Parkinson’s diseaseJournal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 119Issue #:Start Page: 10End Page: 16Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2023.11.019Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11198872Citation Count: 6
-
RESTRICTEDTitle: Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart ReviewJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 41Issue #: 5Start Page: 156End Page: 159Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000296Citation Count: 12
-
OPENTitle: Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicityJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41419-020-03172-8Best OA location URL: https://www.nature.com/articles/s41419-020-03172-8.pdfCitation Count: 20
-
RESTRICTEDTitle: Cough and Swallowing Therapy and Their Effects on Vocal Fold Bowing and Laryngeal LesionsJournal Name: The LaryngoscopePublisher: WileyVol: 134Issue #: 3Start Page: 1127End Page: 1132Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/lary.30922Citation Count: 4
-
OPENTitle: A comprehensive cognitive analysis of cervical dystonia: A single centre studyJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 9Issue #:Start Page: 100226End Page: 100226Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2023.100226Best OA location URL: https://doi.org/10.1016/j.prdoa.2023.100226Citation Count: 2
-
RESTRICTEDTitle: Memory impairment in Parkinson’s disease: The retrieval versus associative deficit hypothesis revisited and reconciled.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 33Issue #: 3Start Page: 391End Page: 405Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1037/neu0000503Citation Count: 30
-
OPENTitle: Exploring the layers of fatigue in Parkinson’s Disease: A comprehensive analysis of its prevalence and contributing factorsJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 11Issue #:Start Page: 100288End Page: 100288Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100288Best OA location URL: https://doi.org/10.1016/j.prdoa.2024.100288Citation Count: 1
-
RESTRICTEDTitle: Retigabine, a KV7 (KCNQ) potassium channel opener, attenuates l-DOPA-induced dyskinesias in 6-OHDA-lesioned ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 62Issue #: 2Start Page: 1052End Page: 1061Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2011.10.016Citation Count: 24
-
OPENTitle: Parkinson-like wild-type superoxide dismutase 1 pathology induces nigral dopamine neuron degeneration in a novel murine modelJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 149Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-025-02859-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-025-02859-6.pdfCitation Count: 1
-
OPENTitle: CoolMPS: evaluation of antibody labeling based massively parallel non-coding RNA sequencingJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 49Issue #: 2Start Page: e10End Page: e10Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/nar/gkaa1122Best OA location URL: https://academic.oup.com/nar/article-pdf/49/2/e10/36084915/gkaa1122.pdfCitation Count: 14
-
OPENTitle: Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PDJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00476-2Best OA location URL: https://www.nature.com/articles/s41531-023-00476-2.pdfCitation Count: 14
-
RESTRICTEDTitle: DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.Journal Name: NeuropharmacologyPublisher: Elsevier BVVol: 131Issue #:Start Page: 116End Page: 127Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2017.11.046Citation Count: 20